Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C

被引：0
|
作者：
Shivakumar Narayanan
Kerry Townsend
Thomas Macharia
Adrian Majid
Amy Nelson
Robert R. Redfield
Shyam Kottilil
Rohit Talwani
Anu Osinusi
机构：
[1] University of Maryland School of Medicine,Division of Infectious Diseases, Institute of Human Virology
[2] National Institutes of Health,Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases
来源：
Hepatology International | 2014年 / 8卷
关键词：
Sofosbuvir; Ribavirin; HCV monoinfection; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：560 / 566
页数：6
相关论文
共 50 条
  • [1] Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C
    Narayanan, Shivakumar
    Townsend, Kerry
    Macharia, Thomas
    Majid, Adrian
    Nelson, Amy
    Redfield, Robert R.
    Kottilil, Shyam
    Talwani, Rohit
    Osinusi, Anu
    HEPATOLOGY INTERNATIONAL, 2014, 8 (04) : 560 - 566
  • [2] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [3] Treatment of hepatitis C with interferon and ribavirin
    Pianko, S
    McHutchison, JG
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (06) : 581 - 586
  • [4] Treatment of Chronic Hepatitis with Sofosbuvir in Combination with Ribavirin with or without Pegylated Interferon
    Sidhu, Sandeep S.
    Malhi, Nirmaljeet
    Singh, Rupinder
    Gover, Rajiv
    Sidhu, Js
    Bansal, Ajesh
    Goyal, Omesh
    Sidhu, Gursewak
    Nanda, Vijay
    Saluja, Harmeet
    Sehgal, Alok
    Simran, Sidhu
    Kishore, Harsh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S383 - S383
  • [5] Hepatitis C and treatment with pegylated interferon and ribavirin
    Gotto, J
    Dusheiko, GM
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (10): : 1874 - 1877
  • [6] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Isakov, Vasily
    Nikitin, Igor
    Chulanov, Vladimir
    Ogurtsov, Pavel
    Lukyanova, Ekaterina
    Long, Jianmin
    Wah, Janice
    Helmond, Frans A.
    WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (06) : 331 - 339
  • [7] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Vasily Isakov
    Igor Nikitin
    Vladimir Chulanov
    Pavel Ogurtsov
    Ekaterina Lukyanova
    Jianmin Long
    Janice Wahl
    Frans A Helmond
    the P08160 trial Investigators
    World Journal of Hepatology, 2016, (06) : 331 - 339
  • [8] Adverse skin reactions induced by hepatitis treatment with interferon and ribavirin
    Dubakiene, R.
    Kvedariene, V
    Stasevskaja, Makarenko L.
    ALLERGY, 2010, 65 : 241 - 242
  • [9] Hepatitis C, Potency of Sofosbuvir plus Ribavirin
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (05): : 416 - 416
  • [10] Mechanism of action of interferon and ribavirin in treatment of hepatitis C
    Jordan J. Feld
    Jay H. Hoofnagle
    Nature, 2005, 436 : 967 - 972
12345